Updates were made at the Fifth World Symposium on PH in Nice, Italy, 2013. Main modifications to the previous Dana Point classification are in bold. BMPR indicates bone morphogenic protein receptor type II; CAV1, caveolin-1; ENG, endoglin; and PAH, pulmonary arterial hypertension.
(Table reprinted with permission from Simonneau et al.17 )